Identification of circadian clock-related immunological prognostic index and molecular subtypes in prostate cancer

被引:0
作者
Che, Lu [1 ]
Li, Dengxiong [2 ]
Wang, Jie [2 ]
Tuo, Zhouting [3 ]
Yoo, Koo Han [4 ]
Feng, Dechao [2 ,6 ]
Ou, Yun [5 ]
Wu, Ruicheng [2 ]
Wei, Wuran [2 ]
机构
[1] Sichuan Univ, West China Hosp, West China Sch Nursing, Dept Anesthesiol,Sch Nursing, Operating Room, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu 610041, Peoples R China
[3] Anhui Med Univ, Dept Urol, Affiliated Hosp 2, Hefei 230601, Peoples R China
[4] Kyung Hee Univ, Dept Urol, Seoul, South Korea
[5] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Peoples R China
[6] UCL, Div Surg & Intervent Sci, London W1W 7TS, England
关键词
Prostate cancer; Circadian clock; Molecular subtypes; Tumor immune environment; GENE-EXPRESSION; RISK; RADIATION; THERAPY; PROGRESSION; CELLS;
D O I
10.1007/s12672-024-01276-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundEvidence suggests that the circadian clock (CIC) is among the important factors for tumorigenesis. We aimed to provide new insights into CIC-mediated molecular subtypes and gene prognostic indexes for prostate cancer (PCa) patients undergoing radical prostatectomy (RP) or radical radiotherapy (RT).MethodsPCa data from TCGA was analyzed to identify differentially expressed genes (DEGs) with significant fold changes and p-values. A prognostic index called CIC-related gene prognostic index (CICGPI) was developed through clustering methods and survival analysis and validated on multiple data sets. The diagnostic accuracy of CICGPI for resistance to chemotherapy and radiotherapy was confirmed. Additionally, the interaction between tumor immune environment and CICGPI score was explored, along with their correlation with prognosis.ResultsTOP2A, APOE, and ALDH2 were used to classify the PCa patients into two subtypes. Cluster 2 had a higher risk of biochemical recurrence (BCR) than cluster 1 for PCa patients undergoing RP or RT. A CIC-related gene prognostic index (CICGPI) was constructed using the above three genes for PCa patents in the TCGA database. The CICGPI score showed good prognostic value in the TCGA database and was externally confirmed by PCa patients in GSE116918, MSKCC2010 and GSE46602. In addition, the CICGPI score had a certain and high diagnostic accuracy for tumor chemoresistance (AUC: 0.781) and radioresistance (AUC: 0.988). For gene set variation analysis, we observed that both beta alanine metabolism and limonene and pinene degradation were upregulated in cluster 1 for PCa patients undergoing RP or RT. For PCa patients undergoing RP, cell cycle, homologous recombination, mismatch repair, and DNA replication were upregulated in cluster 2. A strongly positive relationship between cancer-related fibroblasts and CICGPI score was observed in PCa patients undergoing RP or RT. Moreover, a high density of CAFs was highly closely associated with poorer BCR-free survival of PCa patients.ConclusionsIn this study, we established CIC-related immunological prognostic index and molecular subtypes, which might be useful for the clinical practice.
引用
收藏
页数:16
相关论文
共 83 条
  • [1] Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation
    Aiello, I
    Fedele, M. L. Mul
    Roman, F.
    Marpegan, L.
    Caldart, C.
    Chiesa, J. J.
    Golombek, D. A.
    Finkielstein, C., V
    Paladino, N.
    [J]. SCIENCE ADVANCES, 2020, 6 (42)
  • [2] Circadian Mechanisms in Medicine
    Allada, Ravi
    Bass, Joseph
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (06) : 550 - 561
  • [3] Evidence supporting a circadian control of natural killer cell function
    Arjona, Alvaro
    Sarkar, Dipak K.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2006, 20 (05) : 469 - 476
  • [4] Bayala Bagora, 2020, Pak J Biol Sci, V23, P1184, DOI 10.3923/pjbs.2020.1184.1192
  • [5] Prevalence of incidental prostate cancer: A systematic review of autopsy studies
    Bell, Katy J. L.
    Del Mar, Chris
    Wright, Gordon
    Dickinson, James
    Glasziou, Paul
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (07) : 1749 - 1757
  • [6] Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray, Freddie
    Laversanne, Mathieu
    Sung, Hyuna
    Ferlay, Jacques
    Siegel, Rebecca L.
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (03) : 229 - 263
  • [7] Current therapy and drug resistance in metastatic castration-resistant prostate cancer
    Cai, Maoping
    Song, Xian-Lu
    Li, Xin-An
    Chen, Mingkun
    Guo, Jiading
    Yang, Dong Hua
    Chen, Zhanghui
    Zhao, Shan-Chao
    [J]. DRUG RESISTANCE UPDATES, 2023, 68
  • [8] A Role for the Clock Gene Per1 in Prostate Cancer
    Cao, Qi
    Gery, Sigal
    Dashti, Azadeh
    Yin, Dong
    Zhou, Yan
    Gu, Jiang
    Koeffler, H. Phiflip
    [J]. CANCER RESEARCH, 2009, 69 (19) : 7619 - 7625
  • [9] Revisiting Immunotherapy: A Focus on Prostate Cancer
    Cha, Ha-Ram
    Lee, Joo Hyoung
    Ponnazhagan, Selvarangan
    [J]. CANCER RESEARCH, 2020, 80 (08) : 1615 - 1623
  • [10] Circadian clock and steroidogenic-related gene expression profiles in mouse Leydig cells following dexamethasone stimulation
    Chen, Huatao
    Gao, Lei
    Xiong, Yongjie
    Yang, Dan
    Li, Cuimei
    Wang, Aihua
    Jin, Yaping
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 483 (01) : 294 - 300